NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
13F holders, Q1 2024
Institutional positions in NewAmsterdam Pharma Co N.V. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 76
- +44 vs. Q4 2023
- Shares held
- 72.2M
- +10.3M (+16.6%) vs. Q4 2023
- Total value
- $1.71B
- +$1.01B (+146.8%) vs. Q4 2023
- New holders
- 46
- 13 more added
- Sold out
- 2
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 194 | $4.13B |
| Q1 2026 | 171 | $3.96B |
| Q4 2025 | 187 | $4.19B |
| Q3 2025 | 137 | $3.43B |
| Q2 2025 | 131 | $2.11B |
| Q1 2025 | 126 | $2.28B |
| Q4 2024 | 131 | $2.53B |
| Q3 2024 | 100 | $1.28B |
| Q2 2024 | 90 | $1.38B |
| Q1 2024 | 76 | $1.71B |
| Q4 2023 | 32 | $691.4M |
| Q3 2023 | 35 | $464.1M |
| Q2 2023 | 29 | $580.6M |
| Q1 2023 | 19 | $444.9M |
| Q4 2022 | 14 | $362.2M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding NewAmsterdam Pharma Co N.V.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 12,226,943 | $289.2M | 12.20% | +95,238+0.8% | Added |
| FCPM III Services B.V. | 11,831,461 | $279.8M | 39.56% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 10,473,913 | $247.7M | 19.91% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 8,024,565 | $189.8M | 0.71% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,864,000 | $186.0M | 2.37% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 2,869,565 | $67.9M | 15.11% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,824,601 | $43.2M | 0.08% | +524,601+40.4% | Added |
| BVF Inc | 1,521,948 | $36.0M | 0.99% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,500,000 | $35.5M | 1.56% | +1,500,000 | New |
| Goldman Sachs Group Inc | 1,283,455 | $30.4M | 0.01% | −100,866−7.3% | Reduced |
| Polar Capital Holdings Plc | 1,252,586 | $29.6M | 0.18% | +1,252,586 | New |
| Millennium Management LLC | 947,527 | $22.4M | 0.02% | −378,576−28.5% | Reduced |
| GMT Capital Corp | 943,136 | $22.3M | 0.88% | −440,664−31.8% | Reduced |
| Jennison Associates LLC | 930,851 | $22.0M | 0.01% | +930,851 | New |
| Artal Group S.A. | 800,000 | $18.9M | 0.49% | +800,000 | New |
| Deerfield Management Company, L.P. (Series C) | 667,000 | $15.8M | 0.27% | +667,000 | New |
| Pictet Asset Management Holding SA | 649,736 | $15.4M | 0.02% | +649,736 | New |
| Janus Henderson Group PLC | 636,231 | $15.0M | 0.01% | +636,231 | New |
| Avidity Partners Management LP | 475,000 | $11.2M | 0.40% | +475,000 | New |
| Citadel Advisors LLC | 454,334 | $10.7M | 0.01% | +433,288+2,058.8% | Added |
| Octagon Capital Advisors LP | 408,000 | $9.65M | 1.17% | +408,000 | New |
| Eversept Partners, LP | 353,965 | $8.37M | 0.63% | −20,439−5.5% | Reduced |
| Opaleye Management Inc. | 315,388 | $7.46M | 1.63% | +50,000+18.8% | Added |
| ArrowMark Colorado Holdings LLC | 296,807 | $7.02M | 0.08% | +296,807 | New |
| Affinity Asset Advisors, LLC | 286,200 | $6.77M | 1.10% | +161,200+129.0% | Added |
| AXA S.A. | 249,251 | $5.89M | 0.02% | −27,077−9.8% | Reduced |
| Ensign Peak Advisors, Inc | 246,106 | $5.82M | 0.01% | +54,150+28.2% | Added |
| FMR LLC | 243,700 | $5.76M | 0.00% | +243,700 | New |
| TimesSquare Capital Management, LLC | 228,616 | $5.41M | 0.08% | +228,616 | New |
| Wellington Management Group LLP | 218,082 | $5.16M | 0.00% | +218,082 | New |
| Parkman Healthcare Partners LLC | 200,311 | $4.74M | 0.58% | −100,439−33.4% | Reduced |
| Morgan Stanley | 177,588 | $4.20M | 0.00% | +149,050+522.3% | Added |
| Perceptive Advisors LLC | 175,000 | $4.14M | 0.07% | +175,000 | New |
| Nantahala Capital Management, LLC | 175,000 | $4.14M | 0.41% | +175,000 | New |
| Monashee Investment Management LLC | 170,000 | $4.02M | 0.48% | +170,000 | New |
| Schonfeld Strategic Advisors LLC | 122,000 | $2.89M | 0.02% | +55,100+82.4% | Added |
| Marshall Wace, LLP | 115,380 | $2.73M | 0.00% | +81,439+239.9% | Added |
| Moody Aldrich Partners LLC | 111,267 | $2.63M | 0.45% | +111,267 | New |
| Silverarc Capital Management, LLC | 99,612 | $2.36M | 0.66% | +99,612 | New |
| Baker Bros. Advisors LP | 96,827 | $2.29M | 0.03% | +96,827 | New |
| StemPoint Capital LP | 80,334 | $1.90M | 0.51% | +80,334 | New |
| J. Goldman & Co LP | 78,834 | $1.86M | 0.08% | +78,834 | New |
| Artia Global Partners LP | 54,285 | $1.28M | 0.31% | +54,285 | New |
| Geode Capital Management, LLC | 52,185 | $1.23M | 0.00% | +4,861+10.3% | Added |
| Two Sigma Investments, LP | 51,675 | $1.22M | 0.00% | +51,675 | New |
| UBS Group AG | 48,279 | $1.14M | 0.00% | +47,479+5,934.9% | Added |
| Alyeska Investment Group, L.P. | 35,641 | $842.9K | 0.01% | +35,641 | New |
| Lighthouse Investment Partners, LLC | 29,357 | $694.3K | 0.04% | +29,357 | New |
| Y-Intercept (Hong Kong) Ltd | 26,208 | $619.8K | 0.05% | +26,208 | New |
| Gilder Gagnon Howe & Co LLC | 24,466 | $578.6K | 0.01% | +24,466 | New |
| Yarbrough Capital, LLC | 23,960 | $566.7K | 0.02% | +23,960 | New |
| Cubist Systematic Strategies, LLC | 22,993 | $543.8K | 0.01% | +22,993 | New |
| HealthInvest Partners AB | 22,394 | $529.6K | 0.32% | +22,394 | New |
| SEI Investments Co | 16,474 | $389.6K | 0.00% | +16,474 | New |
| M&T Bank Corp | 15,738 | $372.1K | 0.00% | +15,738 | New |
| Cinctive Capital Management LP | 15,041 | $355.7K | 0.02% | +15,041 | New |
| Glenmede Trust Co NA | 12,665 | $299.5K | 0.00% | +12,665 | New |
| Venture Visionary Partners LLC | 11,700 | $276.7K | 0.01% | +1,700+17.0% | Added |
| BlackRock Inc. | 11,220 | $265.4K | 0.00% | −11,721−51.1% | Reduced |
| Two Sigma Advisers, LP | 9,100 | $215.2K | 0.00% | +9,100 | New |
| Envestnet Asset Management Inc | 9,039 | $213.8K | 0.00% | +9,039 | New |
| Wolverine Asset Management LLC | 7,130 | $168.6K | 0.00% | −1,564−18.0% | Reduced |
| CIBC Private Wealth Group, LLC | 7,640 | $163.3K | 0.00% | +7,640 | New |
| US Bancorp | 6,461 | $152.8K | 0.00% | +6,461 | New |
| JPMorgan Chase & Co | 4,319 | $102.1K | 0.00% | +4,319 | New |
| Royal Bank of Canada | 3,450 | $82.0K | 0.00% | −7,425−68.3% | Reduced |
| Bank of America Corp | 2,000 | $47.3K | 0.00% | +2,000 | New |
| Canton Hathaway, LLC | 1,000 | $24.0K | 0.01% | +1,000 | New |
| Bradley & Co. Private Wealth Management, LLC | 729 | $17.2K | 0.01% | +729 | New |
| Signaturefd, LLC | 647 | $15.3K | 0.00% | +647 | New |
| Wells Fargo & Company | 500 | $11.8K | 0.00% | +200+66.7% | Added |
| PSI Advisors, LLC | 500 | $11.8K | 0.00% | +500 | New |
| Stone House Investment Management, LLC | 325 | $7.69K | 0.00% | +325 | New |
| Barclays PLC | 94 | $2.22K | 0.00% | −419−81.7% | Reduced |
| Principal Securities, Inc. | 5 | $118 | 0.00% | +5 | New |
| DuPont Capital Management Corp | 1 | $24 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Atticus Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |